Metabolic and cardiovascular benefits deriving from β-adrenergic blockade in chronic congestive heart failure

[1]  L. Perlemuter,et al.  Blood Glucose Area Under the Curve: Methodological Aspects , 1990, Diabetes Care.

[2]  L. Groop,et al.  Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. , 1989, The Journal of clinical investigation.

[3]  J. Henriksson,et al.  Indirect Effect of Catecholamines on Development of Insulin Resistance in Skeletal Muscle From Diabetic Rats , 1989, Diabetes.

[4]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[5]  G. Paolisso,et al.  Advantageous metabolic effects of pulsatile insulin delivery in noninsulin-dependent diabetic patients. , 1988, The Journal of clinical endocrinology and metabolism.

[6]  R. DeFronzo.  The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM , 1988, Diabetes.

[7]  M. Packer,et al.  Neurohormonal interactions and adaptations in congestive heart failure. , 1988, Circulation.

[8]  J. Shanes.  Beta-blockade--rational or irrational therapy for congestive heart failure? , 1987, Circulation.

[9]  W. S. Ring,et al.  Heterogeneous myocardial catecholamine concentrations in patients with congestive heart failure. , 1987, The American journal of cardiology.

[10]  G. Paolisso,et al.  Primary role of glucagon release in the effect of beta-endorphin on glucose homeostasis in normal man. , 1987, Acta endocrinologica.

[11]  H. Rosman,et al.  Symptoms and tests of ventricular performance in the evaluation of chronic heart failure. , 1986, American heart journal.

[12]  R. Gunnar,et al.  Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial. , 1985, Circulation.

[13]  J. Horn,et al.  β-Blockers and Glucose Control , 1985, Drug intelligence & clinical pharmacy.

[14]  M. Bristow.  The adrenergic nervous system in heart failure. , 1984, The New England journal of medicine.

[15]  J. Cohn,et al.  Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. , 1984, The New England journal of medicine.

[16]  P. Molinoff,et al.  In vitro interactions of agonists and antagonists with beta-adrenergic receptors. , 1984, Biochemical pharmacology.

[17]  R. DeFronzo,et al.  Effect of fatty acids on glucose production and utilization in man. , 1983, The Journal of clinical investigation.

[18]  J. Fain,et al.  Adrenergic regulation of adipocyte metabolism. , 1983, Journal of lipid research.

[19]  T. K. Harden,et al.  Agonist-induced desensitization of the beta-adrenergic receptor-linked adenylate cyclase. , 1983, Pharmacological reviews.

[20]  M. Caron,et al.  Adenylate cyclase-coupled beta-adrenergic receptors: structure and mechanisms of activation and desensitization. , 1983, Annual review of biochemistry.

[21]  J. Cohn,et al.  Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. , 1982, The American journal of cardiology.

[22]  R. DeFronzo,et al.  Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.

[23]  J. A. Thomas,et al.  Plasma norepinephrine in congestive heart failure. , 1978, The American journal of cardiology.

[24]  D G Pavel,et al.  In vivo labeling of red blood cells with 99mTc: a new approach to blood pool visualization. , 1977, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[25]  M. da Prada,et al.  Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range. , 1976, Life sciences.

[26]  D. Hosmer,et al.  Maximal oxygen intake and nomographic assessment of functional aerobic impairment in cardiovascular disease. , 1973, American heart journal.

[27]  J. Naughton,et al.  Treadmill exercise in assessment of the functional capacity of patients with cardiac disease. , 1972, The American journal of cardiology.

[28]  E. Wareham.  Diseases of the Heart And Blood Vessels: Nomenclature and Criteria for Diagnosis (6th ed.) , 1965 .

[29]  H. M. Marvin.  Diseases of the Heart and Blood Vessels: Nomenclature and Criteria for Diagnosis. , 1964 .

[30]  E. Sutherland,et al.  Adenyl cyclase. II. The enzymatically catalyzed formation of adenosine 3',5'-phosphate and inorganic pyrophosphate from adenosine triphosphate. , 1962, The Journal of biological chemistry.

[31]  R. Steele,et al.  INFLUENCES OF GLUCOSE LOADING AND OF INJECTED INSULIN ON HEPATIC GLUCOSE OUTPUT * , 1959, Annals of the New York Academy of Sciences.